Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: September 3, 2015
Reporting Period: Unaudited interim condensed consolidated financial statements as of June 30, 2015.
Key Financial Metrics
The provided filing text serves as a cover document and exhibit index. It does not contain the actual financial data (revenue, profit, cash flow, margins, debt, or liquidity). These metrics are located in the attached exhibits (99.1 and 99.2) which are incorporated by reference but not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. Such analysis is contained within the "Operating and Financial Review and Prospects" (Exhibit 99.1), which is referenced but not detailed in this document.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, and contingencies are not present in the cover text. This information is expected to be found in Exhibit 99.1 (Operating and Financial Review and Prospects as of June 30, 2015).
Investor Verification Checklist
- Review Exhibit 99.2 for the actual unaudited interim condensed consolidated financial statements as of June 30, 2015.
- Examine Exhibit 99.1 for the Operating and Financial Review, including management discussion of results and prospects.
- Verify the incorporation by reference of this Form 6-K into Registration Statements on Form F-3 (File Nos. 333-195124, 333-199033, and 333-204795).
- Confirm the company's status as a registrant filing under Form 20-F.